01 1Carbogen Amcis AG
01 1Nexera Pharma Korea Co., Ltd.
01 1Clazocentan disodium
01 1Switzerland
Registrant Name : Nexera Pharma Korea Co., Ltd.
Registration Date : 2023-12-07
Registration Number : Su5734-1-ND
Manufacturer Name : Carbogen Amcis AG
Manufacturer Address : Gebaude 171, 173 and 177, Hauptstrasse 171 Bubendorf, 4416, Switzerland
47
PharmaCompass offers a list of Clazosentan Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Clazosentan Sodium manufacturer or Clazosentan Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clazosentan Sodium manufacturer or Clazosentan Sodium supplier.
A Clazosentan Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clazosentan Sodium, including repackagers and relabelers. The FDA regulates Clazosentan Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clazosentan Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Clazosentan Sodium supplier is an individual or a company that provides Clazosentan Sodium active pharmaceutical ingredient (API) or Clazosentan Sodium finished formulations upon request. The Clazosentan Sodium suppliers may include Clazosentan Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Clazosentan Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clazosentan Sodium Drug Master File in Korea (Clazosentan Sodium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clazosentan Sodium. The MFDS reviews the Clazosentan Sodium KDMF as part of the drug registration process and uses the information provided in the Clazosentan Sodium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clazosentan Sodium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clazosentan Sodium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clazosentan Sodium suppliers with KDMF on PharmaCompass.
We have 1 companies offering Clazosentan Sodium
Get in contact with the supplier of your choice:
